News

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...
Discover the top 10 high-yield stocks for June 2025! Learn how to boost income with dividend growth, strong financials, and ...
Pfizer’s current 7.5% dividend yield undeniably offers an excellent income component for investment portfolios. This payout is backed by a history of consistent growth and, importantly, by the ...
This comprehensive analysis examines Pfizer’s current position ... a robust gross profit margin of 74.4% and an attractive dividend yield of 7.38%. The company has demonstrated remarkable ...
This comprehensive analysis examines Pfizer’s current position ... with InvestingPro data showing a robust gross profit margin of 74.4% and an attractive dividend yield of 7.38%. The company has ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...
Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much as Pfizer has, there must be a reason behind the decline. Pfizer faces some ...
A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking investors. Such a substantial return often signals ...
With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical Properties Trust (NYSE: MPW). Pfizer's shares have declined in the past three years ...
the dividend yield represents the annual dividend payment as a percentage of the stock's current price, offering a measure of the income return an investor can expect. Pfizer has a noteworthy ...
However, the drugmaker's story is better than meets the eye. Pfizer's attractive valuation and ultra-high dividend yield make it a great pick right now. 10 stocks we like better than Pfizer ...